In­tas Eyes Teva’s On­col­ogy, Women’s Health Units in Europe

The Economic Times - - Front Page -

Within a year of buy­ing out Teva's UK and Ire­land as­sets, In­tas Phar­ma­ceu­ti­cals is bid­ding for Teva’s women's health, on­col­ogy and pain man­age­ment di­vi­sions in Europe for $1.5 bil­lion, re­ports Ari­jit Bar­man.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.